Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases

A technology for cardiovascular and cerebrovascular diseases and compositions, applied in the field of Chinese patent medicines, can solve the problems of complex causes of cardiovascular and cerebrovascular diseases, pathogenesis and treatment mechanism are not very clear

Inactive Publication Date: 2011-01-26
SOUTHERN MEDICAL UNIVERSITY
View PDF9 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, due to the complex causes of cardiovascular and cerebrovascular diseases, its pathogenesis and treatment mechanism are not yet very clear, so it is necessary to give full play to the advantages of traditional Chinese medicine and develop multi-link, multi-level, multi-target Chinese patent medicines

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases
  • Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases
  • Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0072] 1. Prescription: Panax notoginseng 9g, Astragalus 20g, Salvia 15g, Ginkgo biloba 12g, Hawthorn 12g.

[0073] 2. Preparation method:

[0074] a. Panax notoginseng is ultra-finely pulverized into fine powder with a particle size of not more than 75μm;

[0075] b. Ginkgo biloba leaves are supercritically extracted under the following conditions: add 1 / 5 the amount of medicinal materials as the entrainer, extraction temperature 40℃, extraction pressure 25MPa, analytical pressure 8MPa, CO 2 Extract under the condition of a flow rate of 10L / h, and extract for 1 hour; add 8 volume of β-CD to the obtained extract, stir for 3 hours at room temperature, filter with suction, and dry in vacuo to obtain β-CD inclusion compound, and the medicine residue for later use;

[0076] c. Salvia miltiorrhiza is extracted by percolation method according to the following conditions: crushed into coarse powder, percolated with 90% ethanol of 5 times the amount of medicinal materials, collected the liquid...

example 2

[0081] 1. Prescription: Panax notoginseng 6g, Astragalus 14.5g, Salvia 12g, Ginkgo biloba 10.5g, Hawthorn 10.5g.

[0082] 2. Preparation method:

[0083] a. Panax notoginseng is superfinely pulverized into fine powder with a particle size of not more than 75μm;

[0084] b. Ginkgo biloba leaves are supercritically extracted according to the following conditions: add 1 / 5 the amount of medicinal ethanol as the entrainer, extraction temperature 42℃, extraction pressure 28MPa, analytical pressure 9MPa, CO 2 Extract under the condition of a flow rate of 11L / h, and extract for 1 hour; add 8 volumes of β-CD to the extract, stir for 3 hours at room temperature, filter with suction, and dry in vacuo to obtain β-CD inclusion compound, and the medicine residue for later use;

[0085] c. Salvia miltiorrhiza is extracted by percolation method under the following conditions: crushed into coarse powder, percolated with 90% ethanol of 5 times the amount of medicinal materials, collected the liquid, rec...

example 3

[0090] 1. Prescription: Panax notoginseng 3g, Astragalus 9g, Salvia 9g, Ginkgo biloba 9g, Hawthorn 9g.

[0091] 2. Preparation method:

[0092] a. Panax notoginseng is superfinely pulverized into fine powder with a particle size of not more than 75μm;

[0093] b. Ginkgo biloba leaves are supercritically extracted under the following conditions: add 1 / 5 the amount of medicinal materials as the entrainer, extraction temperature 45℃, extraction pressure 30MPa, analytical pressure 10MPa, CO 2 Extract under the condition of a flow rate of 12L / h, and extract for 1 hour; add 8 volumes of β-CD to the extract, stir at room temperature for 3 hours, filter with suction, and dry in vacuo to obtain β-CD inclusion compound, and the medicine residue for later use;

[0094] c. Salvia miltiorrhiza is extracted by percolation method according to the following conditions: crushed into coarse powder, percolated with 90% ethanol of 5 times the amount of medicinal materials, collected the liquid, recovered ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a Chinese patent medicament taking plants as raw materials, in particular to a Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases. The Chinese medicinal composition consists of active ingredients and pharmaceutically-acceptable auxiliary materials, and is characterized in that the active ingredients are prepared from the following raw material medicaments in part by weight: 3 to 9 parts of notoginseng root, 9 to 20 parts of astragalus, 9 to 15 parts of root of red-rooted salvia, 9 to 12 parts of ginkgo leaf and 9 to 12 parts of hawthorn fruit. The medicaments of a formula are compatible and the Chinese medicinal composition has the effects of invigorating blood circulation and pulse and soothing heart and tonifying qi under the combined action of the medicaments.

Description

Invention field [0001] The invention relates to a medical preparation, in particular to a Chinese patent medicine using plants as raw materials. Background technique [0002] According to a survey by the World Health Organization, the possibility of middle-aged and elderly people suffering from cardiovascular and cerebrovascular diseases exceeds 70% to 80%. Approximately 25 million people worldwide die from cardiovascular and cerebrovascular diseases each year, accounting for more than 50% of the total fatality rate. According to relevant statistics, there are 5 million people who die of cardiovascular and cerebrovascular diseases in my country every year, and the number of deaths jumped from the seventh in the 1960s to the first. The incidence of cardiovascular and cerebrovascular diseases in my country is on the rise. [0003] Cardio-cerebrovascular disease is a general term for cardiovascular disease and cerebrovascular disease. It refers to the heart and brain caused by hypert...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/734A61P9/00A61P25/00A61P29/00A61P9/10A61P7/02
Inventor 易延逵
Owner SOUTHERN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com